Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-02-08 @ 1:12 AM
Study NCT ID:
NCT01706835
Status:
COMPLETED
Last Update Posted:
2022-02-10
First Post:
2012-10-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Investigate the Pharmacolkinetics of Aldoxorubicin (INNO-206;DOXO-EMCH) Administered as a 30 Minute Infusion Every 3 Weeks in Subjects With Advanced Solid Tumors
Sponsor:
ImmunityBio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-10
Start Date Type:
None
Primary Completion Date:
2014-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12
Completion Date Type:
ACTUAL
First Submit Date:
2012-10-11
First Submit QC Date:
None
Study First Post Date:
2012-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-27
Last Update Post Date:
2022-02-10
Last Update Post Date Type:
ACTUAL